Loading…
India Infra Updates on WhatsApp
Join the Tenderkart WhatsApp channel for India Infra Updates
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Company | Status |
|---|---|---|
| 1 | Not yet disclosed by govt. Qualified | Qualified MSE, Category: SC |
| 2 | Not yet disclosed by govt. Qualified | Qualified |
| 3 | Not yet disclosed by govt. Qualified | Qualified MSE, Category: General |
| 4 | Not yet disclosed by govt. Qualified | Qualified MSE, Category: General |
| 5 | Not yet disclosed by govt. Qualified | Qualified MSE, Category: General |
Tender Value
₹93,448.32
EMD Value
Exempted
Closing Date
31 May 2024, 4:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
RE 17 DGLP
6373670
GEM/2024/B/4917261
Two Packet Bid
Tab Oxcarbamazepine 300 mg,Tab Risperidone 2 mg,Tab Resperidone 4 mg,Tab Trifluoperazine 5mg , Eska
30 days
Maharashtra; Pune
Item wise evaluation
PRODUCT
7 documents required · 7 mandatory
3 yrs
₹31
80%
| Item | Delivery Location | Qty | Delivery |
|---|---|---|---|
| ) | - | 90,000 | - |
Exempted
22 Aug 2024
10 May 2024
31 May 2024
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_6373670.pdf
GEM_BID
re-17_specs_2024-05-06-13-40-27_d9d6e6c3823ad90d906bf1e0de8749da.pdf
BOQ
boq_item_sample_file_-4-_-1_2024-05-06-13-40-27_90cc234aa7fc21610cf4d0f5eed374e3.csv
BOQ
world-bank-stc_1704778647.pdf
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .